Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages 738-744

  Davidson, Zoe E ^a   Walker, Karen Z ^a   Truby, Helen ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOCORTICOID; VITAMIN D;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONNECTIVE TISSUE DISEASE; CUSHING SYNDROME; DRUG DOSE COMPARISON; ENTERITIS; EXPERIMENTAL DESIGN; HUMAN; KIDNEY DISEASE; LIVER DISEASE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SAMPLE SIZE; SARCOIDOSIS; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; VITAMIN BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED DISORDER; META ANALYSIS; OSTEOPOROSIS; VITAMIN D DEFICIENCY;

GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84858054171     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2757     Document Type: Review

References (55)

1. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A 2006 Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17:144-149
2. Shaker JL, Lukert BP 2005 Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 34:341-356, viii-ix (Pubitemid 40602725)
3. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000 (Pubitemid 30350061)
4. Canalis E, Mazziotti G, Giustina A, Bilezikian JP 2007 Glucocorticoid- induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328 (Pubitemid 47389469)
5. Borradale D, Kimlin M 2009 Vitamin D in health and disease: an insight into traditional functions and new roles for the 'sunshine vitamin'. Nutr Res Rev 22:118-136
6. Holick MF 2009 Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 19:73-78
7. Holick MF 2007 Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 24:1017-1029 (Pubitemid 350145410)
8. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM 2011 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 96:1911-1930
9. Zittermann A 2006 Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92: 39-48 (Pubitemid 43831966)
10. Holick MF 2011 Vitamin D deficiency in 2010: health benefits of vitamin D and sunlight: a D-bate. Nat Rev Endocrinol 7:73-75
11. Vieth R, Chan PC, MacFarlane GD 2001 Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 73:288-294 (Pubitemid 32109858)
12. Amin S, LaValley MP, Simms RW, Felson DT 1999 The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum 42:1740-1751 (Pubitemid 30263645)
13. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P 2000 Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2:CD000952
14. Kanis JA, Stevenson M, McCloskey EV, Davis S, Lloyd-Jones M 2007 Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 11:iii-iv, ix-xi, 1-231
15. Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG 2010 American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62:1515-1526
16. Bone and Tooth Society, National Osteoporosis Society, Royal College of Physicians 2002 Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. London: Royal College of Physicians of London; 12, 16, 17
17. Avioli LV, Birge SJ, Lee SW 1968 Effects of prednisone on vitamin D metabolism in man. J Clin Endocrinol Metab 28:1341-1346
18. Hahn TJ, Halstead LR, Haddad Jr JG 1977 Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med 90:399-404 (Pubitemid 8167924)
19. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH 1979 Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest 64:655-665 (Pubitemid 9235013)
20. Slovik DM, Neer RM, Ohman JL, Lowell FC, Clark MB, Segre GV, Potts Jr JT 1980 Parathyroid hormone and 25-hydroxyvitamin D levels in glucocorticoid- treated patients. Clin Endocrinol (Oxf) 12: 243-248 (Pubitemid 10184214)
21. Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL 1977 Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 60: 253-259 (Pubitemid 8145163)
22. Seeman E, Kumar R, Hunder GG, Scott M, Heath 3rd H, Riggs BL 1980 Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest 66:664-669 (Pubitemid 10060933)
23. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357:266-281
24. Heaney RP 2005 The vitamin D requirement in health and disease. J Steroid Biochem Mol Biol 97:13-19 (Pubitemid 41546209)
25. American Dietetic Association 2008 Evidence analysis manual: steps in the ADA evidence analysis process. Chicago, IL: Scientific Affairs and Research, American Dietetic Association
26. National Health and Medical Research Council 2009 NHMRC levels of evidence and grades for recommendations for developers of guidelines. Canberra, ACT, Australia: National Health and Medical Research Council
27. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR 2009 Introduction to meta-analysis. West Sussex, UK: John Wiley, Sons Ltd.; 21-32, 69-74
28. Cohen J 1988 Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates; 20-26
29. Bradburn MJ, Deeks JJ, Altman DG 1999 metan: an alternative meta-analysis command. Stata Tech Bull 44:4-15
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003 Measuring inconsistency in meta-analyses. BMJ 327:557-560 (Pubitemid 37088507)
31. Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML 2011 Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab 96: 3838-3845
32. Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ, Hahn BH 1984 Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 27:1336-1343 (Pubitemid 15190897)
33. Colette C, Monnier L, Pares Herbute N, Blotman F, Mirouze J 1987 Calcium absorption in corticoid treated subjects effects of a single oral dose of calcitriol. Horm Metab Res 19:335-338 (Pubitemid 17093226)
34. Rickers H, Deding A, Christiansen C, Rødbro P, Naestoft J 1982 Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. Clin Endocrinol (Oxf) 16:409-415 (Pubitemid 12188633)
35. Zerwekh JE, Emkey RD, Harris Jr ED 1984 Low-dose prednisone therapy in rheumatoid arthritis: effect on vitamin D metabolism. Arthritis Rheum 27:1050-1052 (Pubitemid 14004769)
36. Zhou C, Assem M, Tay JC, Watkins PB, Blumberg B, Schuetz EG, Thummel KE 2006 Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 116:1703-1712
37. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF 2000 Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72:690-693 (Pubitemid 30667088)
38. Elliott ME, Farrah RM, Binkley NC, Carnes ML, Gudmundsson A 2000 Management of glucocorticoid-induced osteoporosis in male veterans. Ann Pharmacother 34:1380-1384
39. Feldstein AC, Elmer PJ, Nichols GA, Herson M 2005 Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int 16:2168-2174 (Pubitemid 41790940)
40. Cruse LM, Valeriano J, Vasey FB, Carter JD 2006 Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. J Clin Rheumatol 12:221-225 (Pubitemid 44527041)
41. Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL 2006 Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 33:1651-1657 (Pubitemid 44168842)
42. Adler RA 2010 Glucocorticoid-induced osteoporosis: management update. Curr Osteoporos Rep 8:10-14
43. Institute of Medicine 2011 Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press
44. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ 2003 Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77:204-210 (Pubitemid 36015393)
45. Hathcock JN, Shao A, Vieth R, Heaney R 2007 Risk assessment for vitamin D. Am J Clin Nutr 85:6-18 (Pubitemid 46067609)
46. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC 2010 Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815-1822
47. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF1 999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 354:1896-1900
48. Schlesselman JJ 1997 Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis. Hum Reprod 12:1851-1863 (Pubitemid 27462459)
49. Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B 1995 Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108: 417-422
50. Adler RA, Funkhouser HL, Petkov VI, Berger MM 2003 Glucocorticoid- induced osteoporosis in patients with sarcoidosis. Am J Med Sci 325:1-6 (Pubitemid 36109681)
51. Als OS, Riis B, Christiansen C 1987 Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol 6:238-243 (Pubitemid 17138674)
52. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F 1995 Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 10:250-256
53. Bikle DD, Halloran B, Fong L, Steinbach L, Shellito J 1993 Elevated 1,25-dihydroxyvitamin Dl evels in patients with chronic obstructive pulmonary disease treated with prednisone. J Clin Endocrinol Metab 76:456-461 (Pubitemid 23073073)
54. D'Angelo A, Fabris A, Sartori L, Malvasi L, Travaglia P, Gambari PF, Todesco S 1985 Mineral metabolism and bone mineral content in rheumatoid arthritis. Effect of corticosteroids. Clin Exp Rheumatol 3:143-146 (Pubitemid 15058053)
55. Grecu EO, Simmons R, Baylink DJ, Haloran BP, Spencer ME 1991 Effects of medroxyprogesterone acetate on some parameters of calcium metabolism in patients with glucocorticoid-induced osteoporosis. Bone Miner 13:153-161